Juvenile Xanthogranuloma, Neurofibromatosis, and Juvenile Chronic Myelogenous Leukemia: World Statistical Analysis

Archives of Dermatology

Volumn 131, Issue 8, 1995, Pages 904-908

  Zvulunov, Alex ^a,c   Barak, Ygal ^b   Metzker, Arieh ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HUMAN; INFANT; JUVENILE XANTHOGRANULOMA; MALE; NEUROFIBROMATOSIS; PRIORITY JOURNAL;

CHILD, PRESCHOOL; FEMALE; HUMAN; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID, CHRONIC; MALE; NEUROFIBROMATOSIS 1; SUPPORT, NON-U.S. GOV'T; XANTHOGRANULOMA, JUVENILE;

EID: 0029114006     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1995.01690200040007     Document Type: Article

References (69)

1. Nomland R. Nevoxanthendothelioma: a benign xanthomatous disease of infants and children. J Invest Dermatol. 1954; 22: 207-215.
2. Whittle CH. Normocholesterolemic xanthomatosis. Trans St Johns Hosp Dermatol Soc. 1968; 41: 93.
3. Marten RH, Sarkany L. Naevoxanthendothelioma with pigmentary abnormalities. Br J Dermatol. 1960; 72: 308.
4. Jensen NE, Sabharwal S, Walker AE. Naevoxanthendothelioma and neurofibromatosis. Br J Dermatol. 1971; 86: 326-330.
5. Newell GB, Stone OJ, Mullins JF. Juvenile xanthogranuloma and neurofibromatosis. Arch Dermatol. 1973; 107: 262.
6. Shusterman M. Naevoxanthendothelioma with ocular involvement: report of a case. J Can Ophthalmol Soc. 1959; 22: 206-215.
7. Germain D, Trouillas P, Robert JM. Leucemies de l'enfant et maladie de Recklinghausen (a propos de 5 observation dont 2 leucemies familial). Nouv Rev Fr Hematol. 1972; 12: 555-560.
8. Crocker AC. Skin xanthomas in childhood. Pediatrics. 1951; 8: 573-597.
9. Sidman J, Wood RE, Poole M, Postma DS. Management of plexiform neurofibroma of the larynx. Ann Otol Rhinol Laryngol. 1987; 96: 53-55.
10. Savova I, Marina S. Xanthogranuloma juvenile combined with neurofibromatosis. Vestn Dermatol Venereol. 1990; 7: 71-73.
11. Sonoda T, Hashimoto H, Enjoji M. Juvenile xanthogranuloma: clinicopatho logic analysis and immunohistochemical study of 57 patients. Cancer. 1985; 56: 2280-2286.
12. Tahan SR, Pastel-Levy C, Bhan AK, Mihm MC. Juvenile xanthogranuloma: clinical and pathologic characterization. Arch Pathol Lab Med. 1989; 113: 1057-1061.
13. Török E, Daróczy J. Juvenile xanthogranuloma: an analysis of 45 cases by clinical follow-up, light-and electron microscopy. Acta Derm Venereol (Stockh). 1985; 65: 167-169.
14. Cohen BA, Hood A. Xanthogranuloma: report on clinical and histologic findings in 64 patients. Pediatr Dermatol. 1989; 6: 262-266.
15. Grier HE. Chronic myeloproliferative disorders and myelodysplasia. In: Nathan DG, Oski FA, eds. Hematology in Infancy and Childhood. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1987: 1064-1085.
16. Bader JL, Miller RW. Neurofibromatosis and childhood leukemia. J Pediatr. 1978; 92: 925-929.
17. Riccardi VM, Eichner JE. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. Baltimore, Md: The Johns Hopkins University Press; 1986: 70.
18. Morier P, Merot Y, Paccaud D, Beck D, Frenk E. Juvenile chronic granulocytic leukemia, juvenile xanthogranuloma and neurofibromatosis. J Am Acad Dermatol. 1990; 22: 962-965.
19. Castro-Malaspina H, Schaison G, Passe S, et al. Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Cancer. 1984; 54: 675-686.
20. Weisgerber C, Schaison G, Chavelet F, Seligman M, Bernard J. Les leucemies myelo-monocytaire de l'enfent: etude de 28 observation. Arch Fr Pediatr. Pediatr. 1972; 29: 11-30.
21. Schaison G, Weisgerber C, Seligman M, Bernard J. Les leucemies myelomonocytaire avec xanthomes. Nouv Rev Fr Hematol. 1970; 10: 284-288.
22. Listernick R, Charrow J. Neurofibromatosis type 1 in childhood. J Pediatr. 1990; 116: 845-853.
23. Helwig EB, Hackney VC. Juvenile xanthogranuloma. Am J Pathol. 1954; 30: 625-626.
24. Riccardi VM. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. 2nd ed. Baltimore, Md: The Johns Hopkins University Press; 1992: 56, 359-387.
25. Niimura M. Aspects in neurofibromatosis from the viewpoint of dermatology. J Dermatol. 1992; 19: 868-872.
26. Pui CH, Crist WM. Leukemia. In: Rudolph AM, Hoffman JIE, Rudolph CD, eds. Rudolph's Pediatrics. 19th ed. East Norwalk, Conn: Appleton & Lange; 1991: 1184-1186.
27. Freedman MH, Estrov Z, Chan HSL. Juvenile chronic granulocytic leukemia. Am J Pediatr Hematol Oncol. 1988; 10: 261-267.
28. Huson SM, Harper PS, Compston AS. Von Recklinghausen neurofibromatosis: a clinical and population study in South-East Wales. Brain. 1988; 111: 1355-1381.
29. North K. Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic. J Child Neurol. 1993; 8: 395-402.
30. Matsui I, Tanimura M, Kobayashi N, Sawada T, Nagahara N, Akatsuka J. Neurofibromatosis type 1 and childhood cancer. Cancer. 1993; 72: 2746-2754.
31. Smitt JHS. Juvenile xanthogranuloma in neurofibromatosis type 1. Br J Dermatol. 1991; 125: 390.
32. Ackerman CD, Cohen BA. Juvenile xanthogranuloma and neurofibromatosis. Pediatr Dermatol. 1991; 8: 339-340.
33. Neiman HL, Mena E, Holt JF, Stern AM, Perry BL. Neurofibromatosis and congenital heart disease. AJR Am J Roentgenol. 1974; 122: 146-149.
34. Mays JA, Neerhout RC, Bagby GC, Koler RD. Juvenile chronic granulocytic leukemia: emphasis on cutaneous manifestations and underlying neurofibromatosis. AJDC. 1980; 134: 654-658.
35. Hardisty RM, Speed DE, Till M. Granulocytic leukemia in childhood. Br J Haematol. 1954; 10: 551-566.
36. Thelander HE. Xanthomatosis. J Pediatr. 1949; 34: 490-496.
37. Cooper PH, Frierson HF, Kayne AL, Sabio H. Association of juvenile xanthogranuloma with juvenile myeloid leukemia. Arch Dermatol. 1984; 120: 371-375.
38. Randal DL, Reiquam CW, Githens JH, Robinson A. Familial myeloproliferative disease. AJDC. 1965; 110: 479-500.
39. Chan HSL, Estrov Z, Weitzman SS, Freedman MH. The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia. J Clin Oncol. 1987; 5: 1960-1967.
40. Clark RD, Hutter JJ Jr. Familial neurofibromatosis and juvenile chronic myelogenous leukemia. Hum Genet. 1982; 60: 230.
41. McWhirter WR, Savage DC, Williams BM. Neurofibromatosis with leukemia. BMJ. 1971; 4: 114-115.
42. Cockington RA. Leukemic infiltration of the gastrointestinal tract. Med J Aust. 1975; 1: 103-105.
43. Arakawa S, Imashuku S, Todo S, Takamatsu T, Sawada T, Miyake M. Juvenile chronic myelocytic leukemia associated with neurofibromatosis and 45,XO karyotype. Rinsho Ketsuki. 1979; 20: 519-527.
44. Matzke E, Winkler K, Grosch-Worner I, et al. Beitrag zur juvenilen chronischen myeloischen Leukamie (JCML): Fallbeschreibung und Verlaufsbeobachtungen bei 9 Patienten. Klin Padiatr. 1980; 192: 157-168.
45. Heskel NS, White CR, Fryberger S, Neerhout RC, Spraker M, Hanifin JM. Aleukemic leukemia cutis: juvenile chronic granulocytic leukemia presenting with figurate cutaneous lesions. J Am Acad Dermatol. 1983; 9: 423-427.
46. Bestak M, Miller DR, Mouradian JS. Juvenile chronic myelogenous leukemia and dermal histiocytosis in von Recklinghausen disease. AJDC. 1979; 133: 831-833.
47. Barak Y, Karov Y. Blood culture for diagnosing juvenile chronic myeloid leukemia: relationship to neurofibromatosis. Harefuah. 1990; 118: 62-66.
48. McEvoy MW, Mann JR. Neurofibromatosis and leukemia. BMJ. 1971; 3: 641.
49. Kaneko Y, Maseki N, Sakurai M, et al. Chromosome patterns in juvenile chronic myelogenous leukemia, myelodysplastic syndrome, and acute leukemia associated with neurofibromatosis. Leukemia. 1989; 3: 36-41.
50. Palmer CG, Provisor AJ, Weaver DD, Hodes ME, Heerema N. Juvenile chronic granulocytic leukemia in a patient with trisomy 8, neurofibromatosis, and EpsteinBarr virus infection. J Pediatr. 1983; 102: 888-892.
51. Shaw NJ, Eden OB. Juvenile chronic myelogenous leukemia and neurofibromatosis in infancy presenting as ocular hemorrhage. Pediatr Hematol Oncol. 1989; 6: 23-26.
52. Emery JL, Lorber J, Sheward JD. Mental retardation, pigmentation of the skin, xanthomatosis and leukemia. Arch Dis Child. 1955; 30: 542-545.
53. Bernheim M, Mouriquand C, François R, Verney R, Bey Y. Réticulose histiomonocytaire du nourisson a forme de xanthomatose cutanée. Pediatrie. 1956; 11: 399-408.
54. Royer P, Blondet C, Guihard J. Xantholeucemie du nourrisson et neurofibromatose de Recklinghausen. Ann Pediatr. 1958; 24: 1504-1513.
55. Mouriquand C, Jeune M, Charrat A, Muller JM. Réticulose histiomonocytaire avec xanthomes cutanés: discussion d'une neurofibromatose associée. Pediatrie. 1960; 15: 683-686.
56. Tilford DL, Heyn RM. Neurofibromatosis and xantholeukemia. J Pediatr. 1978; 93: 319.
57. Leverger G, Schaison G, Boiron M. Leucemies aigues myélomonocytaires de l'enfant avec xanthomes: ‘xantholeucemies.’ Arch Fr Pediatr. 1984; 41: 179-184.
58. Song M, Gheeraert P, Jonckheer T, Achten G. Xanthomes, neurofibromatose et leucémie chez l'enfant. Dermatologica. 1984; 168: 138-140.
59. Laroche L, Leverger G, Verola O, Schaison G, Boiron M, Puissant A. Xantholeucemie associée a une neurofibromatose de von Recklinghausen. Ann Dermatol Venereol. 1985; 112: 731-732.
60. Larregue M, Belaich S, Delzant O, Degos R. Xanthomatoleucemie du jeune enfant et maladie de Recklinghausen. Ann Dermatol Venereol. 1972; 99: 373-380.
61. Liebman SD, Crocker AC, Geiser CF. Corneal xanthomas in childhood. Arch Ophthalmol. 1966; 76: 221-229.
62. Dehen L, Zeller J, Cosnes A, Bernaudin F, Roujeau JC, Revuz J. Xanthogranulomes, neuro fibromatose de type I et leucemie myelomonocytaire spontanement resolutive. Ann Dermatol Venereol. 1990; 117: 812-814.
63. Mosso ML, Castello M, Bellani FF, et al. Neurofibromatosis and malignant child-hood cancers: a survey in Italy, 1973-1983. Tumori. 1987; 73: 209-212.
64. Sórensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. N Engl J Med. 1986; 314: 1010-1015.
65. Gutman DH, Collins FS. The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron. 1993; 10: 335-343.
66. DeClue JE, Papageorge AG, Fletcher JA, et al. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen neurofibromatosis. Cell. 1992; 69: 265-273.
67. Shannon KM, O'Connell P, Martin GA, et al. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med. 1994; 330: 597-601.
68. Chan LC, Kwong YL, Ha SY. Neurofibromatosis and increased risk for leukemia—is the G-CSF gene involved? Leukemia. 1991; 5: 1113-1114.
69. Decker HJ, Cannizaro LA, Mendez MJ, et al. Chromosome 17 and 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease: a cytogenetic and in situ hybridization study. Hum Genet. 1990; 85: 337-342.